UNSPSC 51142532: Melevodopa

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51142532

Definition

This classification denotes a dopamine agonist with the molecular formula C10H13NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M30686U4X4, chemically known as l-tyrosine, 3-hydroxy-, methyl ester (9ci) but generally known as melevodopa, which bears US NIH Compound Identifier 23497. European Medicines Agency schedules Melevodopa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32447.

Read the full definition

The term MELEVODOPA is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 1, 2001, List 45). World Health Organization schedules melevodopa in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule melevodopa under HS 29225000 and SITC 51467. As of Q4 2014, MELEVODOPA remains the US FDA Preferred Term for this commodity. Melevodopa bears US NLM identifiers UMLS ID C0064871 and NCI Concept Code C83927. SMILES: COC(=O)C(CC1=CC(=C(C=C1)O)O)N.

About UNSPSC 51142532

UNSPSC 51142532 Melevodopa is a Commodity code that in recent state and local procurement activity covers emergency pharmaceutical supplies and overdose-reversal medications purchased by public health and emergency-management agencies. The recent solicitation activity under this code shows county health departments and public safety organizations acquiring naloxone (Narcan) and related drug-deactivation systems to support community health and overdose-response initiatives. Issuing bodies soliciting under the code include county health departments and county emergency-management offices working to build inventory and capacity for opioid-overdose intervention and substance-abuse harm reduction.

Seminole County, Florida posted an IFB (Invitation for Bid) on June 30, 2026, seeking annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the bid deadline was July 26, 2023, and bidders were required to include all shipping and delivery costs in their proposals. The contract carries a two-year initial term with an optional one-year renewal, and vendors must meet federal compliance requirements including E-Verify confirmation, drug-free workplace certification, and Clean Air Act and Federal Water Pollution Control Act adherence if FEMA funding is involved. The source reflects limited recent state and local activity under this code; the Seminole County opportunity is the only documented solicitation in the recent-opportunities record, and no other jurisdictions or states appear to be actively procuring under this code at present.

Quick answers

What is UNSPSC 51142532?

UNSPSC 51142532 is Melevodopa, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51142532?

UNSPSC 51142532 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51142532

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code